Molecular genetic and endoscopic studies of duodenal polyposis

Doctoral thesis English OPEN
Hurley, Joanna
  • Subject:
    mesheuropmc: digestive system diseases

Duodenal polyposis and cancer have become a key issue for patients with familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP). The incidence of duodenal adenomas in MAP appears to be lower than in FAP but the very limited available data suggest a comparable increase in relative risk and lifetime risk of duodenal cancer. The work reported in this thesis addressed gaps in current knowledge in endoscopic and molecular genetic aspects of duodenal polyposis in MAP and FAP.\ud A prospective study examined the impact of chromoendoscopy on assessment of the duodenum in MAP and FAP. It demonstrated enhanced adenoma detection in both MAP (p=0.01368) and FAP (p=0.002516), but did not affect measurement of adenoma size. In both conditions there was a significant increase in Spigelman stage after chromoendoscopy compared to endoscopy without dye-spray.\ud A European collaborative project established a cohort of 207 MAP patients who had undergone surveillance upper GI endoscopy. There was a cumulative incidence of 30% of duodenal adenomas, and a 2.3% cumulative incidence of duodenal adenocarcinoma in MAP by 70 years of age. Patients that were Y179C homozygotes had a greater number of duodenal adenomas (and consequently higher Spigelman score) than patients with either two truncating mutations, G396C homozygotes, or G396D / Y179C compound heterozygotes, consistent with a more severe colorectal phenotype previously reported in Y179C homozygotes.\ud To investigate the somatic mutation rate and patterns of mutations in MAP and FAP duodenal adenomas, exome sequencing, Sanger sequencing and arrayCGH of adenoma tissue and matched blood DNA from patients undergoing upper GI surveillance was performed. This demonstrated a higher load of somatic mutation in MAP than FAP adenomas (p=0.035). With the exception of APC and KRAS mutations, there were very few somatic mutations in genes that have been found to drive colorectal tumourigenesis, but several other genes including PLCL1 were found to be recurrently mutated in duodenal adenomas, suggesting that distinct molecular genetic pathways to adenoma development may be operating in the duodenum.
  • References (7)

    Fodde, R., Smits, R., Clevers, H. (2001b) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1:55-67 Ford, D. & Dingwall, A. (2015) The cancer COMPASS: navigating the functions of MLL complexes in cancer. Cancer Genet. 208:178-91 Frayling, I.M., Beck, N.E., Ilyas, M., et al. (1998) The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.

    Proc. Natl. Acad. Sci. U.S.A. 95:10722-10727 Friedl, W., Caspari, R., Sengteller, M. et al. (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515-521 Fu, X., Li, J., Tian., X, et al (2009) Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenoma. Histopathology. 55: 554-565 Fujimoto, A., Totoki, Y., Abe, T. et al (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 44:760-4 Galiatsatos, P. and Foulkes, W.D. (2006) Familial Adenomatous Polyposis. Am. J.

    Gastroenterol. 101:385-398 Gallagher, M., Shankar, A., Groves, C.J. et al. (2004) Pylorus preserving duodenectomy for advanced duodenal disease in familial adenomatous polyposis.

    Br J Surgery. 91:1157-64 Gallinger, S., Vivona, A., Odze, D. et al. (1995) Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. Oncogene. 10: 1975-1878 Gerull, B., Gramlich, M., Atherton, J. et al (2002) Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 30:201-4 Giardello, F.M., Brensinger, J.D., Petersen, G.M. (2001) AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 121:198-213 Hamilton, S.R., Liu, B., Parsons, R.E. et al. (1995) The molecular basis of Turcot's syndrome. N Engl J Med. 332(13):839-47.

    Hollstein, M., Sidransky, D., Vogelstein, B. et al. (1991) p53 mutations in human cancers. Science 253:49-53 Miyaki, M., Tanaka, K., Kikuchi-Yanoshita, R. et al. (1995) Familial polyposis: recent advances. Crit Rev Oncol Hematol. 19:1-31 Pöschl , G. and Seitz, H.K. (2004) Alcohol and cancer. Alcohol. 39(3):155-65.

    Powell, S.M., Zilz, N., Beazer-Barclay, Y. (1992) APC mutations occur early during colorectal tumourigenesis. Nature. 359: 235-7 Pritchard, C. & Grady, W. (2011) Colorectal cancer molecular biology moves into clinical practice. Gut. 60:116-29.

    Rajagopalan, H., Nowak, M.A., Vogelstein, B. et al (2003). The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3: 695-701 Woodford-Richens, K., Rowan, A., Gorman, P. et al (2001) SMAD4 mutations in colorectal cancer probably occur before chromosomal instability,but after divergence of the microsatellite pathway. Proc. Natl. Acad. Sci. U.S.A. 98(17): 9719-9723

  • Related Research Results (1)
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Online Research @ Cardiff - IRUS-UK 0 182
Share - Bookmark